Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Jansen

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
Neurotoxicology|January 1, 1988
Selective behavioural impairment after acute intoxication with trimethyltin (TMT) in ratsJ J Hagan, J H Jansen, C L Broekkamp
Leukemia|January 22, 2010
NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cellsB Hackanson, M Abdelkarim, J H Jansen, et al.
Psychopharmacology|January 1, 1989
Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimeticsJ J Hagan, J H Jansen, C L Broekkamp
Leukemia|October 1, 2004
Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?A O de Graaf, T de Witte, J H Jansen
Leukemia|February 1, 1992
Establishment of a new human B-cell line (BONNA-12) with trisomy 9 and trisomy 12 chromosomal abnormalityJ C Kluin-Nelemans, G J Wientjens, J H Jansen
Molecular and Cellular Endocrinology|August 15, 2000
Retinoic acid receptor fusion proteins: friend or foeM C Breems-de Ridder, B Löwenberg, J H Jansen
Psychopharmacology|August 1, 1994
Effects of disrupting the cholinergic system on short-term spatial memory in ratsJ S Andrews, J H Jansen, S Linders, et al.
Journal of Applied Toxicology : JAT|February 1, 1987
Time development of distribution and toxicity following single toxic APAP doses in male BOM:NMRI miceL A Skoglund, K Ingebrigtsen, I Nafstad, et al.
Expert Opinion on Therapeutic Targets|July 16, 2008
IAPs as therapeutic targets in haematological malignanciesS M C Langemeijer, A O de Graaf, J H Jansen
Annals of Hematology|April 1, 1996
Detection of partial cDNA sequences differentially expressed in patients with myelodysplasiaM J Kroef, J H Jansen, R Willemze, et al.
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
Neurotoxicology|January 1, 1988
Selective behavioural impairment after acute intoxication with trimethyltin (TMT) in ratsJ J Hagan, J H Jansen, C L Broekkamp
Leukemia|January 22, 2010
NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cellsB Hackanson, M Abdelkarim, J H Jansen, et al.
Psychopharmacology|January 1, 1989
Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimeticsJ J Hagan, J H Jansen, C L Broekkamp
Leukemia|October 1, 2004
Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?A O de Graaf, T de Witte, J H Jansen
Leukemia|February 1, 1992
Establishment of a new human B-cell line (BONNA-12) with trisomy 9 and trisomy 12 chromosomal abnormalityJ C Kluin-Nelemans, G J Wientjens, J H Jansen
Molecular and Cellular Endocrinology|August 15, 2000
Retinoic acid receptor fusion proteins: friend or foeM C Breems-de Ridder, B Löwenberg, J H Jansen
Psychopharmacology|August 1, 1994
Effects of disrupting the cholinergic system on short-term spatial memory in ratsJ S Andrews, J H Jansen, S Linders, et al.
Journal of Applied Toxicology : JAT|February 1, 1987
Time development of distribution and toxicity following single toxic APAP doses in male BOM:NMRI miceL A Skoglund, K Ingebrigtsen, I Nafstad, et al.
Expert Opinion on Therapeutic Targets|July 16, 2008
IAPs as therapeutic targets in haematological malignanciesS M C Langemeijer, A O de Graaf, J H Jansen
Annals of Hematology|April 1, 1996
Detection of partial cDNA sequences differentially expressed in patients with myelodysplasiaM J Kroef, J H Jansen, R Willemze, et al.
Pageof 13